Envisagenics Validates AI/ML Approach for RNA Target Identification and SSO Therapeutic Development

Envisagenics, Cancer Research Horizons, and Queen Mary University of London Announce Strategic Collaboration Agreement

Oxford Global – Biologics Analysis – Insight Article – The Black Box Effect – How Can AI and ML Provide Transparent Insights for Drug Discovery?

Envisagenics is Awarded Another SBIR Grant From the National Cancer Institute to Commercialize its AI/ML Platform for Immunotherapy Development

Envisagenics wins another SBIR grant from the National Cancer Institute to enhance their AI/ML platform for Immunotherapy development